| 000 | 01541 a2200289 4500 | ||
|---|---|---|---|
| 008 | 040419s xx 000 0 eng | ||
| 022 | _a1522-3221; | ||
| 050 | _aAC1.S5 | ||
| 082 | _a050 | ||
| 100 | _aLong, Karen R., | ||
| 245 | 0 |
_aResearchers Face Ethical Dilemmas in Third World. _cKaren R. Long. |
|
| 260 |
_bReligion News Service, _c2003. |
||
| 440 |
_aSIRS Enduring Issues 2004. _nArticle 71, _pGlobal Issues, _x1522-3221; |
||
| 500 | _aArticles Contained in SIRS Enduring Issues 2004. | ||
| 500 | _aOriginally Published: Researchers Face Ethical Dilemmas in Third World, Sept. 15, 2003; pp. n.p.. | ||
| 520 | _a"The National Bioethics Advisory Commission declared it unethical for American researchers to test expensive drugs on Third World people unable to afford those treatments. No one, the commissioners declared, should parachute into impoverished places, run their studies and disappear with results that benefit privileged groups living far away." (RELIGION NEWS SERVICE) This article examines ethical dilemmas regarding the testing of drugs in third world countries. | ||
| 599 | _aRecords created from non-MARC resource. | ||
| 650 | _aBioethics | ||
| 650 | _aClinical trials | ||
| 650 |
_aDrugs _xTesting |
||
| 650 | _aHuman experimentation in medicine | ||
| 650 |
_aMedical care _zDeveloping countries |
||
| 650 | _aPharmaceutical ethics | ||
| 650 | _aPharmaceutical industry | ||
| 710 |
_aProQuest Information and Learning Company _tSIRS Enduring Issues 2004, _pGlobal Issues. _x1522-3221; |
||
| 942 | _c UKN | ||
| 999 |
_c35357 _d35357 |
||